Cover |
Aug. 20, 2026 |
|---|---|
| Cover [Abstract] | |
| Document Type | 8-K/A |
| Amendment Flag | true |
| Amendment Description | As previously disclosed in the Current Report on Form 8-K (the “Initial Report”) filed with the Securities and Exchange Commission (the “SEC”) on August 20, 2026, Interpace Biosciences, Inc. (the “Company”) held its annual meeting of stockholders during which stockholders approved the 2026 Benefit Plans (as defined below). This Amendment No. 1 on Form 8-K/A is being filed by the Company to amend the Initial Report, solely to disclose the adoption of the 2026 Benefit Plans. Except as otherwise provided herein, the disclosures made in the Initial Report remain unchanged. As such, this Amendment No. 1 should be read in conjunction with the Initial Report. |
| Document Period End Date | Aug. 20, 2026 |
| Entity File Number | 000-24249 |
| Entity Registrant Name | INTERPACE BIOSCIENCES, INC. |
| Entity Central Index Key | 0001054102 |
| Entity Tax Identification Number | 22-2919486 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | Waterview Plaza |
| Entity Address, Address Line Two | Suite 310 |
| Entity Address, Address Line Three | 2001 Route 46 |
| Entity Address, City or Town | Parsippany |
| Entity Address, State or Province | NJ |
| Entity Address, Postal Zip Code | 07054 |
| City Area Code | (855) |
| Local Phone Number | 776-6419 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Entity Emerging Growth Company | false |